Investing in the U.S. Health System by Lowering Drug Prices, Reducing Out-of-Pocket Costs, and Improving Medicare Benefits

Witnesses: 

Samantha Reid
Patient, Crohn’s Disease
• Testimony

Catherine Alicia Georges EdD, RN, FAAN
National Volunteer President, AARP
• Testimony

Mark E. Miller, PhD
Executive Vice President of Health Care, Arnold Ventures
• Testimony

Judy Feder, PhD
Professor, Georgetown University McCourt School of Public Policy
• Testimony

Benedic N. Ippolito, PhD
Research Fellow, American Enterprise Institute
• Testimony